Literature DB >> 25368133

Red blood cell transfusion is a determinant of neurological complications after cardiac surgery.

Giovanni Mariscalco1, Fausto Biancari2, Tatu Juvonen2, Marco Zanobini3, Marzia Cottini4, Maciej Banach5, Gavin J Murphy6, Cesare Beghi4, Gianni D Angelini7.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the impact of red blood cell (RBC) transfusions on the occurrence of stroke and transient ischaemic attack (TIA) after cardiac surgery.
METHODS: Data on 14 956 patients undergoing coronary artery bypass grafting (CABG) and valve surgery (with or without concomitant CABG) were retrieved at three European University Hospitals. The prognostic impact of RBC transfusion on postoperative stroke and TIA was investigated by logistic regression and multilevel propensity score analysis.
RESULTS: Postoperative stroke was observed in 147 (1.0%) patients and combined stroke/TIA in 238 (1.6%). Of the total population, 6439 (43%) patients received RBC transfusion with a median of 2 units (25th-75th percentile, 2-4 units). When adjusted for other significant risk factors, RBC transfusion was an independent predictor of stroke [odds ratio (OR) 1.14; 95% confidence interval (CI) 1.11-1.17 per unit] and stroke/TIA (OR 1.12; 95% CI 1.09-1.15 per unit). Increase in the amount of transfused RBC units was associated with higher rates of stroke (no RBC transfusion: 0.5%, 1-2 RBC units: 1.0%, OR 1.42; >2 RBC units: 2.7%, OR 3.10) and stroke/TIA (no RBC transfusion: 0.8%, 1-2 RBC units: 1.8%, OR 1.49; >2 RBC units: 4.0%, OR 2.72). Multilevel propensity score analysis confirmed these findings and showed a very high risk of stroke (3.9%; OR 3.85; 95% CI 2.30-6.45) and stroke/TIA (5.9%; OR 3.30; 95% CI 2.17-5.02) associated with transfusion of ≥6 units of RBCs.
CONCLUSIONS: Transfusion of more than 2 units of RBCs after cardiac surgery is associated with a significantly increased risk of postoperative stroke and TIA.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic valve; Blood transfusion; Cardiac surgery; Coronary artery bypass; Mitral valve; Stroke; Transient ischaemic attack

Mesh:

Year:  2014        PMID: 25368133     DOI: 10.1093/icvts/ivu360

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

1.  Routine Application of Bloodless Priming in Neonatal Cardiopulmonary Bypass: A 3-Year Experience.

Authors:  Wolfgang Boettcher; Nicodème Sinzobahamvya; Oliver Miera; Matthias Redlin; Frank Dehmel; Mi-Young Cho; Peter Murin; Felix Berger; Joachim Photiadis
Journal:  Pediatr Cardiol       Date:  2017-02-14       Impact factor: 1.655

2.  A model-based cost-effectiveness analysis of Patient Blood Management.

Authors:  Adina Kleinerüschkamp; Patrick Meybohm; Niels Straub; Kai Zacharowski; Suma Choorapoikayil
Journal:  Blood Transfus       Date:  2018-02-16       Impact factor: 3.443

3.  A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients.

Authors:  Gregory A Nuttall; Mark M Smith; Bradford B Smith; Jon M Christensen; Paula J Santrach; Hartzell V Schaff
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-12-22       Impact factor: 1.889

4.  Measurement of total hemoglobin reduces red cell transfusion in hospitalized patients undergoing cardiac surgery: a retrospective database analysis.

Authors:  Christopher Craver; Kathy W Belk; Gerard J Myers
Journal:  Perfusion       Date:  2017-08-17       Impact factor: 1.972

5.  Neurological complications after cardiac surgery: anesthetic considerations based on outcome evidence.

Authors:  Yong Liu; Kun Chen; Wei Mei
Journal:  Curr Opin Anaesthesiol       Date:  2019-10       Impact factor: 2.706

6.  Red blood cell transfusion induces abnormal HIF-1α response to cytokine storm after adult cardiac surgery.

Authors:  Emma Viikinkoski; Juho Jalkanen; Jarmo Gunn; Tuija Vasankari; Joonas Lehto; Mika Valtonen; Fausto Biancari; Sirpa Jalkanen; K E Juhani Airaksinen; Maija Hollmén; Tuomas O Kiviniemi
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

7.  Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery.

Authors:  Giangiuseppe Cappabianca; Giovanni Mariscalco; Fausto Biancari; Daniele Maselli; Francesca Papesso; Marzia Cottini; Sandro Crosta; Simona Banescu; Aamer B Ahmed; Cesare Beghi
Journal:  Crit Care       Date:  2016-01-06       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.